Search - tctmd.com

Displaying 41 - 60 of 85

Sort: Relevancy | Date

Presentation TCT 2022

Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial

Presenter: Jung-Min Ahn

September 19, 2022

Presentation TCT 2022

TCT 98: The Impact of Frailty on 1-year Mortality After Percutaneous Coronary Intervention in Patients with Complex Coronary Artery Disease and Prohibitive Risk for Bypass Surgery

Presenter: Dan Nguyen

September 18, 2022

News Conference News TCT 2021

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

Michael O'Riordan

November 10, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

Presentation TCT 2020

TCT 528: Successful Percutaneous Treatment of a Catastrophic Left Internal Mammary Artery Graft Avulsion Occurring Four Weeks post Coronary Artery Bypass Grafting Surgery.

Presenter: Shana Tehrani

October 14, 2020

Presentation TCT 2020

TCT 251: Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis

Presenter: Mohamed Farag

October 14, 2020

News Conference News TCT 2019

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

Marcus A. Banks

September 28, 2019

News Conference News TCT 2019

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

Todd Neale

September 28, 2019

Presentation TCT 2018

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

Presenter: Jeroen J. Bax, Seung-Jung Park

September 24, 2018

Presentation TCT 2018

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

Presenter: Jeroen J. Bax, Daniel J.F.M. Thuijs

September 24, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

Shelley Wood

September 24, 2018

Presentation TCT 2018

TCT-108: Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

Presenter: John D. Puskas, Alfredo Trento, Craig Basman

September 21, 2018

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Ashley Lyles

November 08, 2017

News Conference News TCT 2017

Early Pilot Study Results Show Symptom Improvement With TMVR

Michael O'Riordan

November 07, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

TCT 73: Off-Pump versus On-Pump Coronary Artery Bypass Surgery for Left Main Revascularization: Insights From the EXCEL Trial

Presenter: Adrian P. Banning, John D. Puskas, Umberto Benedetto, MD

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

Advertisement

Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial

TCT 98: The Impact of Frailty on 1-year Mortality After Percutaneous Coronary Intervention in Patients with Complex Coronary Artery Disease and Prohibitive Risk for Bypass Surgery

Debating ISCHEMIA: Do the Results Apply to CABG, Too?

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

TCT 528: Successful Percutaneous Treatment of a Catastrophic Left Internal Mammary Artery Graft Avulsion Occurring Four Weeks post Coronary Artery Bypass Grafting Surgery.

TCT 251: Outcomes of Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients With Prior Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

TCT-108: Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Early Pilot Study Results Show Symptom Improvement With TMVR

Long-term Absorb BVS Data Continue to Disappoint

TCT 73: Off-Pump versus On-Pump Coronary Artery Bypass Surgery for Left Main Revascularization: Insights From the EXCEL Trial

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content